Latest Travel News

Experience Co Limited reports robust Q2 2025 earnings growth, driven by strong revenue gains in skydiving and adventure experiences despite ongoing macroeconomic challenges. The company highlights operational efficiencies and positive cash flow amid a gradual inbound tourism recovery.

FlexiRoam Limited reports a modest decline in quarterly cash receipts amid rising operating outflows but counters with strategic marketing optimizations and a director-backed loan to sustain growth.

Astron Corporation has responded to ASX concerns over a delayed Appendix 3Y filing, attributing the lag to director travel and reaffirming its compliance protocols.

Kogan.com reports robust first-half FY25 results with double-digit growth in sales and profits, driven by strategic marketing and a major digital upgrade at Mighty Ape despite initial setbacks.

Fertoz Limited reports solid Q4 2024 sales despite Canadian permit delays and plans a strategic rebrand to Canadian Phosphate Limited to align with its growth ambitions.

Immuron Limited reports a striking 70% quarter-on-quarter increase in Travelan® sales, driven by expanded pharmacy distribution in Australia and North America.

Immuron has submitted its Phase 2 clinical study report for Travelan® to the FDA, revealing statistically significant immunological and microbiome benefits. The company is preparing to engage the FDA for Phase 3 trial discussions while progressing a large field study with military personnel.

Unith Ltd has strengthened its financial position through a partial divestment in AudioStack while renewing a key public health contract and achieving its highest B2C subscription revenue in two years.